Exactly this. My pharmacist said the same thing about Fibrosis regression.

As a pharmacist, I want to add some clinical context to this discussion on Fibrosis regression on GLP-1 is.

Building on what josh_phd_bmore said — the evidence base here is robust. The key publications to reference are from the SELECT program[1].

Key clinical points:

1. Efficacy is dose-dependent and typically requires 4-5 weeks to reach steady state
2. Side effect profile is predictable and usually manageable with standard protocols
3. Monitoring should include baseline labs and follow-up at 3-month intervals
4. Patient education significantly improves outcomes and adherence

Standard disclaimer: this is educational, not individualized medical advice.

Reading this thread on Fibrosis regression on hits close to home. Dad of 2 checking in — I started at 269 lbs and felt like I would tried everything.

15 months on tirz and I am a different person. Not just the 44 lbs lost — my energy, my mood, my relationship with food. All transformed.

If you are on the fence about Fibrosis regression — take the leap. It was the best health decision I have ever made. ❤️

GenomicsKate — that is really helpful context on Fibrosis regression on. Follow-up question: how long did you wait before increasing your dose?

I am in a similar situation (week 4) and trying to set realistic expectations.

To answer tyler_CSCS's question specifically:

From a clinical standpoint, Fibrosis regression on GLP-1 is a reasonable concern that deserves a thorough answer.

The short answer: the evidence supports this approach for most patients.

The longer answer involves reviewing the specific clinical trial data relevant to your question, which I am happy to elaborate on if helpful.